A new analytical method is giving researchers a much clearer picture of how drug-carrying nanoparticles are built. An international team combined particle separation with neutron scattering for the first time, revealing nanoparticles' size, shape, and internal structure in remarkable detail. The advance could help pave the way for safer, more effective targeted therapies.
Scientists have achieved a world first in nanoparticle research by successfully coupling asymmetric-flow field-flow fractionation (AF4) with small-angle neutron scattering (SANS) — two powerful analytical techniques that had never been combined before. The international team, which included researchers from Germany, South Africa, and Sweden, used this new approach to study drug delivery nanoparticles at sub-10 nm resolution, gaining unprecedented insight into their size, shape, and internal organization.
The technique builds on existing methods used to monitor nanoparticle quality during manufacturing. International standards require that nanoparticle sizes within a batch vary by no more than 30% to be considered safe — making precise characterization critical. The new AF4-SANS platform goes further by also revealing how drug molecules are positioned inside the particles, something previous methods couldn't easily achieve.
Key Takeaways:
Why it matters: As targeted drug therapies grow more sophisticated, understanding exactly how nanoparticles are structured becomes essential for ensuring they work as intended — and don't cause harm.
